Keval Vasavada
Director, Consulting
Keval Vasavada comes with a right mix of consulting as well as industry experience in pharmaceutical and life sciences.
He holds over 13 years of experience spanning corporate strategy, operations, new process set-up, new product launches, corporate finance, fund raising and commercial deals. Prior to Clarivate, Keval worked with Cipla Pharmaceuticals and IQVIA Consulting.
He has worked on developing disruptive, competitive and sustainable business model for biosimilar business in his previous assignment. He understands the nuances of biopharma manufacturing and has spearheaded commercial discussions with top suppliers of biopharma equipment in the past.
During his consulting stint, he has led projects involving asset portfolio strategy, market entry strategy, commercial due diligence, opportunity assessment for novel therapies in Japan, Asia-Pacific, US, and Europe. He has a rich exposure of working across a breadth of therapeutic areas involving oncology, immunology, neurology, respiratory, rare diseases, and metabolic disorders.
Keval has completed his MBA from the prestigious Indian Institute of Management, Lucknow (India) and did his B.Tech. in Dairy Technology from Dairy Science College, Anand (Gujarat, India).
Latest news
Clarivate Introduces Nexus, Connecting AI Users to Trusted Academic Resources
Clarivate Nexus integrates academic content and services into the AI tools increasingly used by students and researchers, helping libraries and institutions remain central to trusted scholarship. LONDON, UK — January…
Clarivate empowers libraries to unlock the value of their collections with Alma Specto
AI-powered solution streamlines digital collection management and enriches discovery for researchers and communities London, U.K. January 20, 2026 – Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today…
